Authors: Piccart, MJ Di Leo, A Beauduin, M Vindevoghel, A Michel, J Focan, C Tagnon, A Ries, F Gobert, P Finet, C Closon-Dejardin, MT Dufrane, JP Kerger, J Liebens, F Beauvois, S Bartholomeus, S Dolci, S Lobelle, JP Paesmans, M Nogaret, JM

Citation: Mj. Piccart et al., Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer, J CL ONCOL, 19(12), 2001, pp. 3103-3110

Authors: Rozenberg, S Carly, B Liebens, F Ham, H

Citation: S. Rozenberg et al., Effect of screening programme on mortality from breast cancer - Women might not accept mammography if benefit is lower than is currently thought, BR MED J, 321(7275), 2000, pp. 1527-1528

Authors: Rozenberg, S Liebens, F Ham, H

Citation: S. Rozenberg et al., Screening mammography re-evaluated, LANCET, 355(9205), 2000, pp. 751-752

Authors: Rozenberg, S Ham, H Liebens, F

Citation: S. Rozenberg et al., Screening mammography in elderly women, J AM MED A, 283(24), 2000, pp. 3203-3203

Authors: Rozenberg, S Liebens, F Ham, H

Citation: S. Rozenberg et al., False-negative rates in sentinel-node in breast cancer - Reply, LANCET, 354(9180), 1999, pp. 773-774

Authors: Rozenberg, S Liebens, F Ham, H

Citation: S. Rozenberg et al., The sentinel node in breast cancer: acceptable false-negative rate, LANCET, 353(9168), 1999, pp. 1937-1938